divendres, 31 d’octubre del 2014

U.S. sales narrow HeartWare's Q3 losses




HeartWare posts narrowed 3rd-quarter losses thanks to increased sales of its implantable heart pumps in the U.S.






HeartWare International (NSDQ:HTWR) yesterday reported narrowed 3rd-quarter losses and significantly higher revenues, boosted by a 39% jump in U.S. sales of its implantable heart pumps.




read more






from MassDevice - FDA and Medical device business news and jobs for the medical device industry http://ift.tt/1paHvZE

Cap comentari:

Publica un comentari a l'entrada